UPDATE 3-Gilead asks FDA to take back lucrative orphan drug status on possible coronavirus treatment
March 25, 2020 at 18:08 PM EDT
Gilead Sciences Inc on Wednesday took the unusual step of asking the U.S. Food and Drug Administration to rescind a controversial orphan drug designation the agency had granted for the biotech company's potential coronavirus treatment remdesivir just 48 hours earlier.
